Payment overview · 2025
General Payments
$244.71
2 reported records · 2 companies
Healthcare provider profile · identity verified
Angelo Domenic Michilli, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine · BRONX, NY · NPI 1457462178
Verified facts
What the public records show
CMS Open Payments records show Angelo Domenic Michilli, D.O. received $244.71 in general payments during 2025 across 2 reported records.
Madrigal Pharmaceuticals accounted for 50.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals | Unresolved — no canonical attribution shown | $122.80 | 50.2% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $121.91 | 49.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $244.71 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REZDIFFRA Normalized: rezdiffra |
Drug | Madrigal Pharmaceuticals | $122.80 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $121.91 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 579 | 170 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 469 | 136 |
| Amlodipine Besylate | Amlodipine Besylate | 411 | 121 |
| Losartan Potassium | Losartan Potassium | 399 | 118 |
| Metoprolol Succinate | Metoprolol Succinate | 392 | 111 |
| Simvastatin | Simvastatin | 305 | 91 |
| Lisinopril | Lisinopril | 285 | 73 |
| Levothyroxine Sodium | Levothyroxine Sodium | 276 | 76 |
| Metformin Hcl | Metformin Hcl | 238 | 69 |
| Omeprazole | Omeprazole | 236 | 81 |
| Alprazolam | Alprazolam | 199 | 53 |
| Eliquis | Apixaban | 183 | 43 |
| Pantoprazole Sodium | Pantoprazole Sodium | 178 | 67 |
| Zolpidem Tartrate | Zolpidem Tartrate | 175 | 33 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 166 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 165 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 152 | 47 |
| Glimepiride | Glimepiride | 124 | 36 |
| Famotidine | Famotidine | 104 | 30 |
| Metformin Hcl Er | Metformin Hcl | 102 | 29 |
| Meloxicam | Meloxicam | 100 | 33 |
| Gabapentin | Gabapentin | 98 | 34 |
| Furosemide | Furosemide | 96 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 95 | 28 |
| Tamsulosin Hcl | Tamsulosin Hcl | 92 | 37 |
| Lorazepam | Lorazepam | 91 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 84 | 26 |
| Montelukast Sodium | Montelukast Sodium | 82 | 28 |
| Synthroid | Levothyroxine Sodium | 81 | 24 |
| Sertraline Hcl | Sertraline Hcl | 80 | 26 |
| Alendronate Sodium | Alendronate Sodium | 74 | 24 |
| Allopurinol | Allopurinol | 73 | 24 |
| Clonazepam | Clonazepam | 73 | 13 |
| Clopidogrel | Clopidogrel Bisulfate | 72 | 23 |
| Azithromycin | Azithromycin | 70 | 64 |
| Ozempic | Semaglutide | 69 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 67 | 17 |
| Valsartan | Valsartan | 63 | 18 |
| Atenolol | Atenolol | 62 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 58 | 31 |
| Ezetimibe | Ezetimibe | 56 | 16 |
| Carvedilol | Carvedilol | 53 | 17 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 53 | 25 |
| Duloxetine Hcl | Duloxetine Hcl | 50 | 15 |
| Tramadol Hcl | Tramadol Hcl | 49 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 48 | 12 |
| Metoprolol Tartrate | Metoprolol Tartrate | 47 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 44 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 42 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | 12 |
| Methylprednisolone | Methylprednisolone | 40 | 31 |
| Potassium Chloride | Potassium Chloride | 39 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 36 | 34 |
| Finasteride | Finasteride | 36 | 12 |
| Jardiance | Empagliflozin | 36 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 35 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 35 | 12 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 35 | suppressed |
| Bupropion Xl | Bupropion Hcl | 34 | 12 |
| Nifedipine Er | Nifedipine | 33 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 32 | suppressed |
| Chlorthalidone | Chlorthalidone | 32 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 32 | suppressed |
| Spironolactone | Spironolactone | 31 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 24 |
| Entresto | Sacubitril/Valsartan | 29 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 29 | 14 |
| Ramipril | Ramipril | 29 | suppressed |
| Telmisartan | Telmisartan | 29 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 27 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 27 | suppressed |
| Xarelto | Rivaroxaban | 27 | suppressed |
| Hydrocortisone | Hydrocortisone | 26 | 12 |
| Klor-Con M20 | Potassium Chloride | 26 | suppressed |
| Naproxen | Naproxen | 26 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 26 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 25 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 25 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 24 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 24 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 23 | suppressed |
| Diazepam | Diazepam | 23 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 23 | suppressed |
| Ativan | Lorazepam | 22 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 22 | suppressed |
| Glipizide | Glipizide | 22 | suppressed |
| Glipizide Er | Glipizide | 22 | suppressed |
| Irbesartan | Irbesartan | 22 | suppressed |
| Prednisone | Prednisone | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 13 |
| Valacyclovir | Valacyclovir Hcl | 21 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 20 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 20 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 19 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Vascepa | Icosapent Ethyl | 19 | suppressed |
| Colchicine | Colchicine | 18 | 12 |
| Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 18 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Levetiracetam | Levetiracetam | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 15 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 14 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Pregabalin | Pregabalin | 13 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 13 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 13 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 12 | suppressed |
| Levemir | Insulin Detemir | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Mirtazapine | Mirtazapine | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Multaq | Dronedarone Hcl | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Novolog | Insulin Aspart | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $244.71 · 2 records | Madrigal Pharmaceuticals | REXULTI, REZDIFFRA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error